glp 1/gip receptor agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Design of a novel long-acting

glp 1/gip receptor agonist

glp 1/gip receptor agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Design of a novel long-acting

Name: glp 1/gip receptor agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Design of a novel long-acting
Brand: studiovaccarone.it
SKU: 19155238274
Price: 20.88 USD
Availability: InStock
Rating: 4.1305 (26 reviews)

SKU: 19155238274

4.1

USD20.88 USD46.88

Pay in 4 interest-free payments of $5.22 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Pain 155 , 10271036 (2014)

The results showed that VRK2 knockdown could induce an increase of ROS and decline of cell viability and GSH following TBHP treatment, while these alterations could be partly reversed by ectopic SLC7A11 expression but not GCLC or GSS expression (Fig